07/22/2025

Tempus to Report Second Quarter 2025 Financial Results on August 8

CHICAGO, July 22, 2025 Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the second quarter of 2025 on Friday, August 8, 2025. The company will hold the earnings conference call at 8:00 a.m. ET. The company’s quarterly earnings will be released the same day. 

The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus’ Investor Relations website. Alternatively, the call can be accessed via the following:


About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com. 

Contacts

Tempus Communications

Erin Carron

Erin.carron@tempus.com

Tempus Investor Relations

Elizabeth Krutoholow

investorrelations@tempus.com 

Related Content

View more
  • post image
    08/12/2025

    What’s Next in Oncology: Research Breakthroughs from the 2025 ASCO® Annual Meeting

    Join us for a cross-functional discussion exploring what’s next in oncology, driven by the latest innovations shaping cancer care today. We’ll highlight breakthrough research from the 2025 ASCO® Annual Meeting, including new clinical data from SERENA-6, DESTINY-Breast09, and MATTERHORN. You’ll also hear insights from Tempus’ own ASCO presentations, including new data from our xM MRD assay. Register now to reserve your spot and stay informed on the evolving role of precision medicine in oncology.

    Watch replay
  • post image
    07/29/2025

    Navigating New Frontiers in Breast Cancer Care Gap Closure: The Role of Providers and AI

    Learn how AI and care pathway intelligence are transforming breast cancer care, featuring insights from providers at Mercy Health System. Discover how Tempus Next harnesses AI to integrate multimodal clinical data with up-to-date guidelines, supporting personalized care and the identification of potential care gaps. Secure your recording now.

    Watch replay
  • post image
    07/14/2025

    Closing Care Gaps with AI: The Next Competitive Edge in Pharma

    Discover how Tempus is equipping life sciences teams with innovative AI and data analytics strategies to fully leverage their understanding of therapy trends, provider practices, and patient care. Secure your recording now.

    Watch replay